138 related articles for article (PubMed ID: 8681459)
1. TPA decreases the p53 response to benzo[a]pyrene-DNA adducts in vivo in mouse skin.
Tapiainen T; Järvinen K; Pääkko P; Bjelogrlic N; Vähäkangas K
Carcinogenesis; 1996 Jun; 17(6):1377-80. PubMed ID: 8681459
[TBL] [Abstract][Full Text] [Related]
2. Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin.
Bjelogrlic NM; Mäkinen M; Stenbäck F; Vähäkangas K
Carcinogenesis; 1994 Apr; 15(4):771-4. PubMed ID: 8149494
[TBL] [Abstract][Full Text] [Related]
3. Thapsigargin has similar effect on p53 protein response to benzo[a]pyrene-DNA adducts as TPA in mouse skin.
Serpi R; Piispala J; Järvilehto M; Vähäkangas K
Carcinogenesis; 1999 Sep; 20(9):1755-60. PubMed ID: 10469621
[TBL] [Abstract][Full Text] [Related]
4. The tumor promoter TPA enhances benzo[a]pyrene and benzo[a]pyrene diolepoxide mutagenesis in Big Blue mouse skin.
Miller ML; Vasunia K; Talaska G; Andringa A; de Boer J; Dixon K
Environ Mol Mutagen; 2000; 35(4):319-27. PubMed ID: 10861950
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase.
Mukherjee JJ; Sikka HC
Carcinogenesis; 2006 Mar; 27(3):631-8. PubMed ID: 16244358
[TBL] [Abstract][Full Text] [Related]
7. p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines.
Rämet M; Castrén K; Järvinen K; Pekkala K; Turpeenniemi-Hujanen T; Soini Y; Pääkkö P; Vähäkangas K
Carcinogenesis; 1995 Sep; 16(9):2117-24. PubMed ID: 7554063
[TBL] [Abstract][Full Text] [Related]
8. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
9. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
Rojas M; Alexandrov K
Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285
[TBL] [Abstract][Full Text] [Related]
10. Impact of GSTM1 on aromatic-DNA adducts and p53 accumulation in human skin and lymphocytes.
Godschalk RW; Ostertag JU; Zandsteeg AM; Van Agen B; Neuman HA; Van Straaten H; Van Schooten FJ
Pharmacogenetics; 2001 Aug; 11(6):537-43. PubMed ID: 11505223
[TBL] [Abstract][Full Text] [Related]
11. Oxygen radical-dependent epoxidation of (7S,8S)-dihydroxy-7,8-dihydrobenzo[a]pyrene in mouse skin in vivo. Stimulation by phorbol esters and inhibition by antiinflammatory steroids.
Ji C; Marnett LJ
J Biol Chem; 1992 Sep; 267(25):17842-8. PubMed ID: 1325452
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy.
Beranek M; Fiala Z; Kremlacek J; Andrys C; Hamakova K; Chmelarova M; Palicka V; Borska L
Toxicol Lett; 2016 Jul; 255():47-51. PubMed ID: 27188524
[TBL] [Abstract][Full Text] [Related]
13. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation.
Suh M; Ariese F; Small GJ; Jankowiak R; Hewer A; Phillips DH
Carcinogenesis; 1995 Oct; 16(10):2561-9. PubMed ID: 7586167
[TBL] [Abstract][Full Text] [Related]
14. Lack of contribution of covalent benzo[a]pyrene-7,8-quinone-DNA adducts in benzo[a]pyrene-induced mouse lung tumorigenesis.
Nesnow S; Nelson G; Padgett WT; George MH; Moore T; King LC; Adams LD; Ross JA
Chem Biol Interact; 2010 Jul; 186(2):157-65. PubMed ID: 20346927
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach.
van Schooten FJ; Hillebrand MJ; Scherer E; den Engelse L; Kriek E
Carcinogenesis; 1991 Mar; 12(3):427-33. PubMed ID: 1901249
[TBL] [Abstract][Full Text] [Related]
16. Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.
John K; Pratt MM; Beland FA; Churchwell MI; McMullen G; Olivero OA; Pogribny IP; Poirier MC
Carcinogenesis; 2012 Nov; 33(11):2236-41. PubMed ID: 22828138
[TBL] [Abstract][Full Text] [Related]
17. Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice.
Godschalk R; Curfs D; Bartsch H; Van Schooten FJ; Nair J
Free Radic Res; 2003 Dec; 37(12):1299-305. PubMed ID: 14753754
[TBL] [Abstract][Full Text] [Related]
18. Formation and persistence of benzo[a]pyrene--DNA adducts in different tissues of C57BL/10 and DBA/2 mice.
Brauze D; Mikstacka R; Baer-Dubowska W
Carcinogenesis; 1991 Sep; 12(9):1607-11. PubMed ID: 1909937
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of mice with benzo[a]pyrene or parenteral administration of benzo[a]pyrene diol epoxide-DNA to rats results in faecal excretion of a putative benzo[a]pyrene diol epoxide-deoxyguanosine adduct.
Tierney B; Martin CN; Garner RC
Carcinogenesis; 1987 Sep; 8(9):1189-92. PubMed ID: 3113751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
